Introduction Pancreatic exocrine insufficiency is a finding in many conditions, predominantly
affecting those with chronic pancreatitis, pancreatic cancer and acute necrotising …

This is a medical position statement developed by the Exocrine Pancreatic Insufficiency
collaborative group which is a part of the Italian Association for the Study of the Pancreas …

Background Exocrine pancreatic insufficiency (EPI) is characterized by a deficiency of
exocrine pancreatic enzymes, resulting in malabsorption. Numerous conditions account for …

Aim Because of increasing awareness of variations in the use of pancreatic exocrine
replacement therapy, the Australasian Pancreatic Club decided it was timely to re-review the …

Awareness of PEI in different clinical conditions is required. Nutritional advice and
appropriate PERT are mandatory to reduce the morbidity and mortality associated with PEI …

Exocrine pancreatic insufficiency (EPI) is characterized by inadequate pancreatic enzyme
delivery to the small intestine Exocrine pancreatic insufficiency (EPI) is characterized by …

Increasing evidence supports the relevance of PEI management by dietary advice and
appropriate PERT. Well designed and powered randomized, placebo-controlled clinical …

Background Pancreatic cancer is the fourth leading cause of cancer mortality. Most patients
are diagnosed with advanced pancreatic cancer, either at locally advanced or metastatic …

Exocrine pancreatic insufficiency (EPI) is defined as the maldigestion of foods due to
inadequate pancreatic secretion, which can be caused by alterations in its stimulation …

Exocrine pancreatic insufficiency (EPI), an important cause of maldigestion and
malabsorption, results from primary pancreatic diseases or secondarily impaired exocrine …